Normative base EN ISO 13485:2016 Medical devices – Quality Management System Reg. no. 37081 Validity 01.03.2022 – 28.02.2025 Issue 01.03.2022 Swiss Made Swiss Association for Quality and Management Systems (SQS) Bernstrasse 103, 3052 Zollikofen, Switzerland sqs.ch F.

Validity of this certificate is based on the successful completion of the periodic surveillance audits of the management system defined by the above scope and is contingent upon prompt,written notification to ABS Quality Evaluations, Inc. of significant changes to the management system or components thereof.

LUXURY CLOSURE MANUFACTURER S P I R I T B O T T L E C A P D I S K • Specific gravity of 2.6 to match incumbent metal weight • Polypropylene-based material suitable for physical vapor deposition (PVD) surface treatment • Provided an easy-to-process material with an excellent surface finish for metallization • Met custom weight target and used a magnetic filler to support the magnetic system in the PVD metallization process • Enabled more design freedom by eliminating metal working Gravi-Tech™ Density Modified Formulation KEY REQUIREMENTS WHY AVIENT?

LUXURY CLOSURE MANUFACTURER L U X U R Y S P I R I T C A P • Specific gravity of 2.2 • White color for metallic surface treatment • Touch and feel of ceramic • FDA compliant material • Formulated a custom, ABS-based material suitable for electroplating to achieve desired weight, look, and feel of metal • Combined material, electroplating, and application experience and expertise to support the process from concept to production Gravi-Tech™ Density Modified Formulation KEY REQUIREMENTS WHY AVIENT?

Based on the language/region you select, the date format will automatically update.

AVIENT SOLUTION DURABILITY + COLLABORATION • Water-based antioxidant dispersion to use in self-adhesive skin bandages • Durability and preservation of bandage adhesive • Efficient development and production KEY REQUIREMENTS LEARN MORE Copyright © 2024, Avient Corporation.

These various elastomers contain a propriety combina- tion of base resins, processing aids, fillers, stabilization packages, and other additives. present broad-spectrum efficacy, a more favorable eco- nomic position relative to alternative transition metal counterparts (i.e., silver and copper-based antimicro- bials), and have a long history of use in anti-dandruff shampoo and soaps.[29,30] For these reasons, ZPT was elected for further study. For a base- line understanding, ZPT was compounded into these aforementioned products at nominal loading levels rang- ing from 1000–3000 ppm.

They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. Sustainable Development Goals • Emphasized climate change commitment o Announced 2050 operational carbon neutrality and RE100 commitment o Alignment to Science Based Targets Reduce Scope 1 & 2 greenhouse gas emissions by 60%. Develop and implement solutions to end plastic waste while supporting AEPW $1.5B investment in key initiatives. 2 0 3 0 S U STA I NA B I L I T Y TA RG E TS 27 Sustainalytics 2021 ESG Risk Ranking RANK (1st = lowest risk) PERCENTILE (1st – lowest risk) Chemicals INDUSTRY 75/449 17th Specialty Chemicals SUBINDUSTRY 21/124 17th AV I E N T E S G R AT I N G S ISS November 2021 ESG Scores SCORE (1 = Best, 10 = Worst) Environmental 2 Social 1 Governance 4 28 2 0 2 1 AV I E N T I N V E S TO R DAY 29 • Investor Day to be held 2021年12月9日 in New York, NY • The company will be doing a deep dive into its key long- term growth drivers with a particular focus on sustainable solutions Revenue Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Healthcare 8–10% Composites / 5G 10% Growth in Asia / LATAM 5% Other (GDP growth) 2–3% Avient 6.5% • Senior leadership team will also provide further details on the Clariant Color integration, as well as capital allocation priorities PEER COMPARISONS 30 As a specialty formulator, we don’t require significant capital investment, as compared to the base resin raw material suppliers we purchase from.

They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. FX +4.6% FX -1.5% Total Avient +3.1% Note: Regional Sales Percentages exclude impact of foreign exchange Q2 2024 SEGMENT PERFORMANCE ( C O L O R , A D D I T I V E S & I N K S ) $525 $542 Q2 23 Q2 24 $94 $108 Q2 23 Q2 24 19.9% Sales Adjusted EBITDA (in millions) (in millions) Sales Adjusted EBITDA 10 17.9% +200 bps * * * Adjusted EBITDA Margin % • Organic sales growth in all regions led by Americas • Raw material deflation combined with cost reduction actions drove EBITDA margin expansion + 3% (+5% excluding FX) + 15% (+17% excluding FX) Q2 2024 SEGMENT PERFORMANCE ( S P E C I A LT Y E N G I N E E R E D M AT E R I A L S ) $301 $308 Q2 23 Q2 24 $60 $64 Q2 23 Q2 24 20.6% Sales Adjusted EBITDA (in millions) (in millions) Sales Adjusted EBITDA 11 19.8% +80 bps * * * Adjusted EBITDA Margin % • Sales growth in consumer, healthcare and building & construction end markets offset by weaker demand in telecommunications • EBITDA margin expansion driven by positive end market mix as well as raw material deflation + 2% (+4% excluding FX) + 7% (+8% excluding FX) 2 0 2 4 G U I D A N C E FY 20 24 GUIDA NC E Previous (May 7) Current Adjusted EBITDA $510 to $535 million $515 to $540 million Adjusted EPS $2.50 to $2.65 $2.55 to $2.70 Interest Expense $105 million $105 million Adjusted Effective Tax Rate 23% to 25% 23% to 25% Capital Expenditures ~$140 million ~$140 million 13 Q3 2024: Adjusted EPS of $0.62 14 Highlights • Provides performance updates on 2030 Sustainability Goals • Reduced company’s Scope 1 & 2 GHG emissions by 48% since 2019 • Highlights ESG performance ratings, certifications, and awards, including recent upgrades by Ecovadis to Gold and CDP to A- • Reflects Great Place to Work® culture focused on health, safety and employee engagement 20 23 SUSTAI NA BILI TY REPORT 14 Sustainability for a Better Tomorrow 2023 SUSTAINABILITY REPORT 15 • Investor Day to be held 2024年12月4日 in New York, NY • The focus will be to do a deep dive on the Company’s strategy • Further details to be communicated 20 24 AVI ENT INVESTOR DAY A P P E N D I X 18 Performance Additives 15% Pigments 13% TiO2 9% Dyestuffs 2% Polyethylene 10%Nylon 5% Polypropylene 4% Styrenic Block Copolymer 4% Other Raw Materials 38% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials RA W MATERI AL BA SKET SEGMENT DATA U.S. & Canada 41% EMEA 36% Asia 18% Latin America 5% 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 19% Packaging 23%Industrial 16% Building and Construction 9% Telecommunications 4% Energy 5% Defense 7% END MARKET REVENUE $2,007M $358M $1,138M $224M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $502M$3,143M (1) Transportation 10% Healthcare 7% 20 (1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs 2 0 2 3 R E V E N U E | $ 2 . 0 B I L L I O N US & Canada 34% EMEA 37% Asia 21% Latin America 8% END MARKET REGION 21 Packaging 34% Consumer 21% Healthcare 8% Industrial 15% Transportation 9% Building & Construction 10% Telecommunications 1% Energy 2% COLOR , AD DI TI VES & INKS 2 0 2 3 R E V E N U E | $ 1 . 1 B I L L I O N US & Canada 52% EMEA 35% Asia 13% 22 Packaging 5% Consumer 16% Healthcare 6%Industrial 16% Transportation 12% Telecommunications 9% Energy 10% Defense 18% Building & Construction 8% END MARKET REGION SPEC IA LTY ENGI NEER ED MATERI ALS Packaging 32% Consumer 26% Healthcare 9% Industrial 13% Building & Construction 6% Telecommunications 2% Energy 2% Defense 1% Asia (18% of sales) Transportation 9% 2 0 2 3 AV I E N T R E G I O N A L S A L E S Packaging 25% Consumer 13% Healthcare 5% Industrial 18% Building & Construction 9% Energy 5% Defense 8% EMEA (36% of sales)Transportation 13% Packaging 13% Consumer 22% Healthcare 10% Industrial 16% Building & Construction 12% Energy 6% Defense 8% US & Canada (41% of sales) Transportation 9% Packaging 59% Consumer 22% Healthcare 2% Industrial 8% Building & Construction 4% LATAM (5% of sales) Transportation 5% Telecommunications 4% Telecommunications 4% 23 B Y E N D M A R K E T Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results. Senior management believes the measures described above are useful to investors because they allow for comparison to Avient's performance in prior periods without the effect of items that, by their nature, tend to obscure Avient's operating results due to the potential variability across periods based on timing, frequency and magnitude.

They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. For the same reasons, Avient is unable to address the probable significance of the unavailable information. 2 3 Q3 2024 HIGHLIGHTS • 8.5% organic sales growth driven by broad-based growth across all regions and most end markets in both CAI and SEM segments • Growth stemmed from gaining share, winning new product specifications and restocking in certain end markets • Both segments expanded YoY EBITDA margins by 40 bps each • Adjusted EPS of $0.65, an increase of 14% vs the prior year • Successfully refinanced $650M outstanding senior notes due 2025; extending maturity to 2031 • Increased dividend 5% to $1.08 on an annualized basis; 14th consecutive increase Adj. Senior management believes the measures described above are useful to investors because they allow for comparison to Avient's performance in prior periods without the effect of items that, by their nature, tend to obscure Avient's operating results due to the potential variability across periods based on timing, frequency and magnitude.